600267.SH
Zhejiang Hisun Pharmaceutical Co., Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 12.06
−7.80%Margins
Gross margin
46.9%
EBITDA margin
17.7%
EBIT margin
10.7%
Net margin
6.8%
FCF margin
17.1%
7.8%
Return on equity
5.1%
Return on assets
10.6%
Return on invested capital
0.71x
Asset turnover
CNY 2.2B
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026